FDA Drug Approval, A062423, NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

FDA Drug Approval, A062423, NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out

Contents: Summary Basis of Approval

ANDA: 062423
Company: SANDOZ
Drug Name: NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Active Ingredients: HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength: 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Dosage Form/Route: SOLUTION/DROPS;OTIC
Action Date: 08/25/1983
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AT

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details